Intravenous administration of adenosine triphosphate and phosphocreatine combined with fluoxetine in major depressive disorder: protocol for a randomized, double-blind, placebo-controlled pilot study

New targets for rapid antidepressant action

(2017) Rodrigo Machado-Vieira et al.   PROGRESS IN NEUROBIOLOGY

The potential of transcranial photobiomodulation therapy for treatment of major depressive disorder

(2017) Farzad Salehpour et al.   REVIEWS IN THE NEUROSCIENCES

Social defeat stress causes depression-like behavior with metabolite changes in the prefrontal cortex of rats

(2017) Yi-Yun Liu et al.   PLoS One

The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression

(2016) Lanxiang Liu et al.   BEHAVIOURAL BRAIN RESEARCH

Effects of Creatine Monohydrate Augmentation on Brain Metabolic and Network Outcome Measures in Women With Major Depressive Disorder

(2016) Sujung Yoon et al.   BIOLOGICAL PSYCHIATRY

Psychiatric disorders biochemical pathways unraveled by human brain proteomics

(2016) Verônica M. Saia-Cereda et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

Antidepressant Effects of Open Label Treatment With Coenzyme Q10 in Geriatric Bipolar Depression

(2015) Brent P. Forester et al.   JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY

Transitioning health systems for multimorbidity

(2015) Rifat Atun   LANCET

Sparse whole-genome sequencing identifies two loci for major depressive disorder

(2015) Na Cai et al.   NATURE

Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum

(2015) Wei-hua Shao et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients

(2014) Marlijn Vermeiden et al.   PSYCHOPHARMACOLOGY

The INDDEP study: inpatient and day hospital treatment for depression – symptom course and predictors of change

(2013) Almut Zeeck et al.   BMC Psychiatry

World Medical Association Declaration of Helsinki

(2013)   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

A review of ketamine in affective disorders: Current evidence of clinical efficacy, limitations of use and pre-clinical evidence on proposed mechanisms of action

(2013) Marie Naughton et al.   JOURNAL OF AFFECTIVE DISORDERS

Astrocyte-derived ATP modulates depressive-like behaviors

(2013) Xiong Cao et al.   NATURE MEDICINE

Coenzyme Q10 displays antidepressant-like activity with reduction of hippocampal oxidative/nitrosative DNA damage in chronically stressed rats

(2013) Sawsan Aboul-Fotouh   PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR

Epidemiology of Major Depressive Disorder in Mainland China: A Systematic Review

(2013) Lian Gu et al.   PLoS One

Effects of acupuncture treatment on depression insomnia: a study protocol of a multicenter randomized controlled trial

(2013) Yuan-Fang Chen et al.   Trials

World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders

(2013) Michael Bauer et al.   WORLD JOURNAL OF BIOLOGICAL PSYCHIATRY

Creatine Phosphate: Pharmacological and Clinical Perspectives

(2012) Ettore Strumia et al.   ADVANCES IN THERAPY

A Randomized, Double-Blind Placebo-Controlled Trial of Oral Creatine Monohydrate Augmentation for Enhanced Response to a Selective Serotonin Reuptake Inhibitor in Women With Major Depressive Disorder

(2012) In Kyoon Lyoo et al.   AMERICAN JOURNAL OF PSYCHIATRY

SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial Function

(2012) Nathan L. Price et al.   Cell Metabolism

Open-label adjunctive creatine for female adolescents with SSRI-resistant major depressive disorder: A 31-phosphorus magnetic resonance spectroscopy study

(2011) Douglas G. Kondo et al.   JOURNAL OF AFFECTIVE DISORDERS

Towards a glutamate hypothesis of depression

(2011) Gerard Sanacora et al.   NEUROPHARMACOLOGY

Mitochondrial Complex I Activity and Oxidative Damage to Mitochondrial Proteins in the Prefrontal Cortex of Patients With Bipolar Disorder

(2010) Ana C. Andreazza et al.   ARCHIVES OF GENERAL PSYCHIATRY

Mitochondrial trafficking and the provision of energy and calcium buffering at excitatory synapses

(2010) Andrew F. MacAskill et al.   EUROPEAN JOURNAL OF NEUROSCIENCE

Beyond the serotonin hypothesis: Mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders

(2010) Ann Gardner et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The GRID-HAMD: standardization of the Hamilton Depression Rating Scale

(2009) Janet B.W. Williams et al.   INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY

31Phosphorus magnetic resonance spectroscopy study of tissue specific changes in high energy phosphates before and after sertraline treatment of geriatric depression

(2009) Brent P. Forester et al.   INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY

Brain Bioenergetics and Response to Triiodothyronine Augmentation in Major Depressive Disorder

(2008) Dan V. Iosifescu et al.   BIOLOGICAL PSYCHIATRY